Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80376 refers to a laboratory test that is conducted to definitively, qualitatively, or quantitatively measure drug(s) or substance(s) that are not otherwise specified. This code is specifically utilized when the testing involves a range of four to six different drugs or compounds. The methodologies employed in these tests are advanced and may include techniques such as gas chromatography, liquid chromatography, and tandem mass spectrometry, either individually or in combination. These methods are essential for accurately identifying and quantifying the presence of various substances in a patient sample. It is important to note that this code is part of a broader coding system where different codes are assigned based on the number of substances being tested: CPT® Code 80375 is designated for tests involving one to three substances, while CPT® Code 80377 is applicable for tests that identify seven or more substances. This structured approach to coding ensures clarity and precision in laboratory testing and reporting.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 80376 is indicated for use in situations where there is a need to perform a laboratory test to measure the presence of multiple drugs or substances in a patient sample. This may include scenarios where a healthcare provider suspects substance use, monitors therapeutic drug levels, or evaluates potential drug interactions. The specific indications for this code include:
The procedure associated with CPT® Code 80376 involves several key steps to ensure accurate testing of the specified drugs or substances. The procedural steps include:
After the procedure associated with CPT® Code 80376, the patient may not require any specific post-procedure care, as the testing is non-invasive and typically involves only the collection of a sample. However, it is essential for healthcare providers to review the results thoroughly and discuss them with the patient. Depending on the findings, further actions may be necessary, such as adjusting medication dosages, initiating treatment for substance use disorders, or conducting additional tests. Continuous monitoring may also be recommended based on the results to ensure patient safety and effective management of their health conditions.
| Short Descr | DRUG/SUBSTANCE NOS 4-6 | Medium Descr | DRUG/SUBSTANCE DEFINITIVE QUAL/QUANT NOS 4-6 | Long Descr | Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 4-6 | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
| SA | Nurse practitioner rendering service in collaboration with a physician |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.